Trial Profile
Prediction of treatment efficacy and telaprevir-resistant variants by genotype sequencing after treatment with telaprevir/peginterferon/ribavirin
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Dec 2015
Price :
$35
*
At a glance
- Drugs Telaprevir (Primary) ; Peginterferon; Ribavirin
- Indications Hepatitis C
- Focus Pharmacodynamics
- 23 Dec 2015 New trial record